313 related articles for article (PubMed ID: 33105105)
1. MANAGEMENT OF ENDOCRINE DISEASE: Rationale and current evidence for testosterone therapy in the management of obesity and its complications.
Lapauw B; Kaufman JM
Eur J Endocrinol; 2020 Dec; 183(6):R167-R183. PubMed ID: 33105105
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.
Hackett G
Sex Med Rev; 2019 Jul; 7(3):476-490. PubMed ID: 30803918
[TBL] [Abstract][Full Text] [Related]
3. Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism.
Giagulli VA; Carbone MD; Ramunni MI; Licchelli B; De Pergola G; Sabbà C; Guastamacchia E; Triggiani V
Andrology; 2015 Nov; 3(6):1094-103. PubMed ID: 26447645
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy has positive effects on anthropometric measures, metabolic syndrome components (obesity, lipid profile, Diabetes Mellitus control), blood indices, liver enzymes, and prostate health indicators in elderly hypogonadal men.
Canguven O; Talib RA; El Ansari W; Yassin DJ; Salman M; Al-Ansari A
Andrologia; 2017 Dec; 49(10):. PubMed ID: 28295504
[TBL] [Abstract][Full Text] [Related]
5. Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels.
Pelusi C; Fanelli F; Baccini M; Triggiani V; Bartolomeo N; Carbone MD; De Pergola G; Di Dalmazi G; Pagotto U; Pasquali R; Giagulli VA
Clin Endocrinol (Oxf); 2020 Jan; 92(1):38-45. PubMed ID: 31677181
[TBL] [Abstract][Full Text] [Related]
6. Hypogonadal obese men with and without diabetes mellitus type 2 lose weight and show improvement in cardiovascular risk factors when treated with testosterone: an observational study.
Haider A; Saad F; Doros G; Gooren L
Obes Res Clin Pract; 2014; 8(4):e339-49. PubMed ID: 25091355
[TBL] [Abstract][Full Text] [Related]
7. Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome.
Jones TH
J Diabetes; 2010 Sep; 2(3):146-56. PubMed ID: 20923480
[TBL] [Abstract][Full Text] [Related]
8. Testosterone in obesity, metabolic syndrome and type 2 diabetes.
Stanworth R; Jones T
Front Horm Res; 2009; 37():74-90. PubMed ID: 19011290
[TBL] [Abstract][Full Text] [Related]
9. Hypogonadism and male obesity: Focus on unresolved questions.
Grossmann M
Clin Endocrinol (Oxf); 2018 Jul; 89(1):11-21. PubMed ID: 29683196
[TBL] [Abstract][Full Text] [Related]
10. The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes.
Groti K; Žuran I; Antonič B; Foršnarič L; Pfeifer M
Aging Male; 2018 Sep; 21(3):158-169. PubMed ID: 29708829
[TBL] [Abstract][Full Text] [Related]
11. Obesity, low testosterone levels and erectile dysfunction.
Diaz-Arjonilla M; Schwarcz M; Swerdloff RS; Wang C
Int J Impot Res; 2009; 21(2):89-98. PubMed ID: 18843273
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis and treatment of late-onset hypogonadism: systematic review and meta-analysis of TRT outcomes.
Corona G; Rastrelli G; Maggi M
Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):557-79. PubMed ID: 24054931
[TBL] [Abstract][Full Text] [Related]
13. Testosterone Therapy and Glucose Homeostasis in Men with Testosterone Deficiency (Hypogonadism).
Saad F
Adv Exp Med Biol; 2017; 1043():527-558. PubMed ID: 29224109
[TBL] [Abstract][Full Text] [Related]
14. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
15. [Testosterone and the metabolic syndrome].
Schubert M; Jockenhövel F
Urologe A; 2010 Jan; 49(1):47-50. PubMed ID: 20063085
[TBL] [Abstract][Full Text] [Related]
16. The Role of testosterone treatment in patients with metabolic disorders.
Corona G; Rastrelli G; Vignozzi L; Barbonetti A; Sforza A; Mannucci E; Maggi M
Expert Rev Clin Pharmacol; 2021 Sep; 14(9):1091-1103. PubMed ID: 34085587
[TBL] [Abstract][Full Text] [Related]
17. Late-onset hypogonadism: metabolic impact.
Grossmann M; Ng Tang Fui M; Cheung AS
Andrology; 2020 Nov; 8(6):1519-1529. PubMed ID: 31502758
[TBL] [Abstract][Full Text] [Related]
18. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
Traish AM; Guay A; Feeley R; Saad F
J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
[TBL] [Abstract][Full Text] [Related]
19. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: a review.
Saad F; Aversa A; Isidori AM; Gooren LJ
Curr Diabetes Rev; 2012 Mar; 8(2):131-43. PubMed ID: 22268394
[TBL] [Abstract][Full Text] [Related]
20. Testosterone and obesity.
Kelly DM; Jones TH
Obes Rev; 2015 Jul; 16(7):581-606. PubMed ID: 25982085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
